---
title: "Huakang Clean (301235): Won the procurement project of the Agricultural Products Quality Inspection and Testing Center in Tongzhou District, Beijing, with a bid amount of 7.0209 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287340007.md"
description: "Huakang Clean (301235) won the bid for the procurement project of the Agricultural Products Quality Inspection and Testing Center in Tongzhou District, Beijing, with an amount of 7.0209 million yuan. The operating revenue for 2024 is expected to be 1.708 billion yuan, with a growth rate of 6.64%; the net profit is expected to be 67 million yuan, a decrease of 37.75%. In the first half of 2025, the operating revenue is expected to be 835 million yuan, with a growth rate of 50.73%; the net profit is expected to be 19 million yuan, an increase of 273.48%"
datetime: "2026-05-22T09:36:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287340007.md)
  - [en](https://longbridge.com/en/news/287340007.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287340007.md)
generator: "portal-rs"
---

# Huakang Clean (301235): Won the procurement project of the Agricultural Products Quality Inspection and Testing Center in Tongzhou District, Beijing, with a bid amount of 7.0209 million yuan

According to Tongbi Finance, data from Qichacha shows that based on the "Announcement of the Successful Bid for the Partial Interior Decoration Project of Building 22, No. 2 Yunsong Road, Tongzhou District (New Laboratory Project of the Agricultural Product Quality Inspection and Testing Center in Tongzhou District)," Wuhan Huakang Century Clean Technology Co., Ltd. announced on May 22, 2026, that it won the bid for the procurement project of the Agricultural Product Quality Inspection and Testing Center in Tongzhou District, Beijing, with a bid amount of 7.0209 million yuan.

Related listed company: Huakang Clean (301235.SZ)

*Tongbi Finance Tip:*

*Huakang Clean (301235.SZ) reported an operating income of 1.708 billion yuan in 2024, with a growth rate of 6.64%. The net profit attributable to the parent company was 67 million yuan, with a net profit growth rate of -37.75%, and a return on equity of 3.78%.*

*In the first half of 2025, the company's operating income was 835 million yuan, with a growth rate of 50.73%. The net profit attributable to the parent company was 19 million yuan, with a net profit growth rate of 273.48%.*

*The company currently belongs to the healthcare industry, with main product types being medical auxiliary equipment and medical consumables. In the 2024 report, the main business composition was: medical purification system integration: 87.75%; medical consumables sales: 8.17%; operation and maintenance services: 2.26%; medical equipment sales: 1.1%; other business income: 0.72%.*

### Related Stocks

- [301235.CN](https://longbridge.com/en/quote/301235.CN.md)

## Related News & Research

- [14:12 ETYour Telehealth Doctor Must Be Licensed in the State You're In, Not the State They're In, Promise Analysis Finds](https://longbridge.com/en/news/296525345.md)
- [Negative Link Announces Global Expansion and Next Phase of Growth](https://longbridge.com/en/news/296644416.md)
- [The Sandbox SAND Exploit: $49B in New Tokens Flood Base](https://longbridge.com/en/news/296678246.md)
- [11:19 ETEon Appoints Matthew Lungren, MD, MPH, to Board of Directors](https://longbridge.com/en/news/296375443.md)
- [Asker Healthcare Group buys Baltic medtech distributor Ambercell Solutions](https://longbridge.com/en/news/296306272.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**